speb/financial-data huggingface dataset:
Financial ratios for HITI — annual report dated 2023-10-31
Total revenue: 353383333.3333334
Gross profit: 95155072.46376812
Operating income: -1928260.8695652175
Net income: -28485507.246376812
Capital expenditures: 4192753.623188406
Operating cash flow: 14971739.130434783
Depreciation & amortization: 23739855.07246377
Net tangible assets: 20341304.34782609
Owner earnings: -8938405.79710145
Return on net tangible assets (%): -43.9421466994407
Buffett classification: The Gruesome
Stock price: 1.45
Shares outstanding: 87870176
Book value: 96859420.2898551
P/B ratio: 1.3154296692951084
Market cap (USD): 127411755.2
Debt to equity: 0.5426211602052877
Current ratio: 1.1807454805029498
Quick ratio: 0.7339732012315736
Interest coverage ratio: -0.22870648904168459
COGS to revenue (%): 73.07312952022787
SG&A to revenue (%): 20.754651208094018
Free cash flow (dilution-adjusted): 6917391.304347828
Buyback yield (%): 0
Retained earnings: -149227536.23188406
Inventory turnover: 13.71968121968122
Receivables turnover: 64.39574805229104
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.5182809932444767
FCF margin (%): 1.957475254732206
Revenue growth (%): 34.67805514144055
Rule of 40 score: 36.63553039617276
Financial ratios for HITI — annual report dated 2024-10-31
Total revenue: 375759712.23021585
Gross profit: 102519424.46043167
Operating income: 11018705.035971224
Net income: -2741726.618705036
Capital expenditures: 6508633.093525181
Operating cash flow: 25572661.8705036
Depreciation & amortization: 18268345.323741008
Net tangible assets: 36299280.575539574
Owner earnings: 9017985.61151079
Capex to operating income (%): 59.06894750587621
Buffett classification: The Good
Stock price: 2.82
Shares outstanding: 87870176
Book value: 104684892.08633094
P/B ratio: 2.3670454387596895
Market cap (USD): 247793896.32
Debt to equity: 0.5127618340755402
Current ratio: 1.3953968770331815
Quick ratio: 0.9182010409889395
Interest coverage ratio: 1.1972172281716564
COGS to revenue (%): 72.71675990702768
SG&A to revenue (%): 19.489150038483192
Free cash flow (dilution-adjusted): 16417985.611510793
Buyback yield (%): 0
Retained earnings: -150617266.18705037
Inventory turnover: 12.945804076624174
Receivables turnover: 157.8917775090689
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.291109090121692
FCF margin (%): 4.369277779692364
Revenue growth (%): 6.332041380054465
Rule of 40 score: 10.701319159746829
Financial ratios for HITI — quarterly report dated 2024-10-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.82
Shares outstanding: 87870176
Market cap (USD): 247793896.32
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HITI — quarterly report dated 2025-01-31
Total revenue: 98248965.51724139
Gross profit: 24441379.31034483
Operating income: 1071034.4827586208
Net income: -1854482.7586206896
Capital expenditures: 1857931.0344827587
Operating cash flow: 470344.8275862069
Depreciation & amortization: 4032413.7931034486
Net tangible assets: 34671724.137931034
Owner earnings: 320000.00000000023
Capex to operating income (%): 173.4707018673535
Buffett classification: The Gruesome
Stock price: 2.79
Shares outstanding: 87870176
Book value: 100068965.51724139
P/B ratio: 2.4498883322398344
Market cap (USD): 245157791.04
Debt to equity: 0.4586285320468642
Current ratio: 1.6088853975735358
Quick ratio: 0.9456009426551454
Interest coverage ratio: 0.43295232785057153
COGS to revenue (%): 75.12301612371105
SG&A to revenue (%): 19.682579793768117
Free cash flow (dilution-adjusted): -2230344.827586207
Buyback yield (%): 0
Retained earnings: -146321379.31034485
Inventory turnover: 3.5207750764878116
Receivables turnover: 41.1380306092983
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.8180788579555931
FCF margin (%): -2.2700949733611306
Rule of 40 score: -2.2700949733611306
Financial ratios for HITI — quarterly report dated 2025-04-30
Total revenue: 99857971.01449277
Gross profit: 25703623.1884058
Operating income: 1722463.7681159421
Net income: -2055072.4637681162
Capital expenditures: 1762318.8405797102
Operating cash flow: 5982608.695652175
Depreciation & amortization: 4260869.565217392
Net tangible assets: 35869565.217391305
Owner earnings: 443478.2608695652
Capex to operating income (%): 102.31384097602019
Buffett classification: The Gruesome
Stock price: 2.41
Shares outstanding: 87870176
Book value: 102835507.24637683
P/B ratio: 2.0592802022422187
Market cap (USD): 211767124.16000003
Debt to equity: 0.4468935192688478
Current ratio: 1.5689370178859032
Quick ratio: 0.9707764685937104
Interest coverage ratio: 0.7350030921459493
COGS to revenue (%): 74.25981829264752
SG&A to revenue (%): 19.74833821950016
Free cash flow (dilution-adjusted): 3221014.4927536235
Buyback yield (%): 0
Retained earnings: -155843478.26086956
Inventory turnover: 3.6254871395167583
Receivables turnover: 50.07412790697674
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.2863110957184292
FCF margin (%): 3.2255957737075844
Revenue growth (%): 1.6376818715399273
Rule of 40 score: 4.8632776452475115
Financial ratios for HITI — quarterly report dated 2025-07-31
Total revenue: 108471014.49275362
Gross profit: 29051449.27536232
Operating income: 3900724.6376811597
Net income: 602898.5507246377
Capital expenditures: 1610869.5652173914
Operating cash flow: 7717391.304347827
Depreciation & amortization: 4405797.101449275
Net tangible assets: 37639855.07246377
Owner earnings: 3397826.0869565215
Return on net tangible assets (%): 9.027202895481585
Capex to operating income (%): 41.29667471670072
Buffett classification: The Good
Stock price: 2.19
P/E ratio: 79.79604744807692
Shares outstanding: 87870176
Book value: 103978985.50724639
P/B ratio: 1.8507170896237393
Market cap (USD): 192435685.44
Debt to equity: 0.5601884438745287
Current ratio: 1.8480886209172478
Quick ratio: 1.290497511550331
Effective tax rate (%): 7.658157602663708
Interest coverage ratio: 1.6116766467065868
COGS to revenue (%): 73.21731578595765
SG&A to revenue (%): 19.12485803994923
Free cash flow (dilution-adjusted): 5509420.289855073
Buyback yield (%): 0
Retained earnings: -155410144.92753625
Inventory turnover: 3.506270394778937
Receivables turnover: 42.15432272599268
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.63446385748544
FCF margin (%): 5.079163604783219
Revenue growth (%): 8.625293895677908
Rule of 40 score: 13.704457500461128
Financial ratios for HITI — annual report dated 2025-10-31
Total revenue: 424275714.2857143
Gross profit: 109664285.71428572
Operating income: 11026428.571428573
Net income: -36247857.14285714
Capital expenditures: 7455714.285714286
Operating cash flow: 17047142.85714286
Depreciation & amortization: 17364285.714285716
Net tangible assets: -29957142.85714286
Owner earnings: -26339285.714285713
Capex to operating income (%): 67.61676491546285
Buffett classification: The Good
Stock price: 3.11
Shares outstanding: 87870176
Book value: 73419285.71428573
P/B ratio: 3.722131653847275
Market cap (USD): 273276247.36
Debt to equity: 1.4488018912897542
Current ratio: 1.3699596673305379
Quick ratio: 0.6953532361212582
Interest coverage ratio: 1.1537369207772796
COGS to revenue (%): 74.15258945497033
SG&A to revenue (%): 19.15583868980077
Free cash flow (dilution-adjusted): 6644285.714285715
Buyback yield (%): 0
Retained earnings: -185789285.71428573
Inventory turnover: 6.53437379461769
Receivables turnover: 105.78557435440784
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.196040025206408
FCF margin (%): 1.566030175795389
Revenue growth (%): 12.91144326451216
Rule of 40 score: 14.477473440307548
Financial ratios for HITI — quarterly report dated 2025-10-31
Total revenue: 117165000
Gross profit: 30377142.85714286
Operating income: 4374285.714285715
Net income: -32599285.714285716
Capital expenditures: 2168571.4285714286
Operating cash flow: 3055714.285714286
Depreciation & amortization: 4645000
Net tangible assets: -29957142.85714286
Owner earnings: -30122857.142857146
Capex to operating income (%): 49.57544088830829
Buffett classification: The Good
Stock price: 3.11
Shares outstanding: 87870176
Book value: 73419285.71428573
P/B ratio: 3.722131653847275
Market cap (USD): 273276247.36
Debt to equity: 1.4488018912897542
Current ratio: 1.3699596673305379
Quick ratio: 0.6953532361212582
Interest coverage ratio: 1.8959752321981425
COGS to revenue (%): 74.07319348171993
SG&A to revenue (%): 18.22887137187483
Free cash flow (dilution-adjusted): 348571.42857142864
Buyback yield (%): 0
Retained earnings: -185789285.71428573
Inventory turnover: 1.8025546687238525
Receivables turnover: 29.21300089047195
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.4580261135171364
FCF margin (%): 0.297504739957691
Revenue growth (%): 8.015031064199343
Rule of 40 score: 8.312535804157035
Financial ratios for HITI — quarterly report dated 2026-01-31
Total revenue: 132095555.55555555
Gross profit: 32895555.555555552
Operating income: 3062222.222222222
Net income: 892592.5925925926
Capital expenditures: 1734814.8148148146
Operating cash flow: 4340740.740740741
Depreciation & amortization: 5945185.185185185
Net tangible assets: -28882222.22222222
Owner earnings: 5102962.962962963
Return on net tangible assets (%): -17.668179836372495
Capex to operating income (%): 56.652152878567975
Buffett classification: The Good
Stock price: 2.23
P/E ratio: 54.882399346058094
Shares outstanding: 87870176
Book value: 75547407.4074074
P/B ratio: 2.5937421177577975
Market cap (USD): 195950492.48
Debt to equity: 1.488611516928296
Current ratio: 1.4341621460316107
Quick ratio: 0.7237740996919929
Interest coverage ratio: 0.840585603904026
COGS to revenue (%): 75.0971518934105
SG&A to revenue (%): 18.0839908259453
Free cash flow (dilution-adjusted): 2067407.4074074072
Buyback yield (%): 0
Retained earnings: -191777777.77777776
Inventory turnover: 2.009151601530268
Receivables turnover: 20.561397440332065
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.6366249262647816
FCF margin (%): 1.5650847590689119
Revenue growth (%): 12.74318743272782
Rule of 40 score: 14.308272191796732
Financial ratios for HZR.AX — annual report dated 2021-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.631578947368421
Shares outstanding: 267847838
Market cap (USD): 169167055.57894737
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HZR.AX — annual report dated 2022-06-30
Operating income: -11781218.620689655
Net income: -11320569.655172413
Capital expenditures: 7948.275862068966
Depreciation & amortization: 53430.34482758621
Net tangible assets: 8587563.448275862
Owner earnings: -11275087.586206896
Return on net tangible assets (%): -131.29553748415813
Buffett classification: The Gruesome
Stock price: 0.5103448275862069
Shares outstanding: 267847838
Book value: 8587563.448275864
P/B ratio: 15.917758224062105
Market cap (USD): 136694758.7034483
Debt to equity: 0.3066748410110627
Current ratio: 2.1546195711008274
Quick ratio: 2.1546195711008274
Interest coverage ratio: -27.121357943937102
Free cash flow (dilution-adjusted): -14688568.27586207
Buyback yield (%): 0
Retained earnings: -33788400.68965517
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -117.26725739288737
Rule of 40 score: 0
Financial ratios for HZR.AX — annual report dated 2023-06-30
Operating income: -9629360.264900662
Net income: -8083178.145695364
Capital expenditures: 13685.430463576158
Depreciation & amortization: 73680.79470198676
Net tangible assets: 2608925.1655629138
Owner earnings: -8023182.781456953
Return on net tangible assets (%): -307.52828357672854
Buffett classification: The Gruesome
Stock price: 0.40397350993377484
Shares outstanding: 267847838
Book value: 2608925.1655629147
P/B ratio: 41.47433305994678
Market cap (USD): 108203431.24503312
Debt to equity: 0.06631895553648363
Current ratio: 1.922577167190428
Quick ratio: 1.922577167190428
Interest coverage ratio: -39.19914270694326
Free cash flow (dilution-adjusted): -3823856.2913907287
Buyback yield (%): 0.012489351889558072
Retained earnings: -39202678.145695366
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -233.5161537593069
Rule of 40 score: 0
Financial ratios for HZR.AX — annual report dated 2024-06-30
Operating income: -15126784.666666666
Net income: -12711577.333333334
Capital expenditures: 4998438.666666667
Depreciation & amortization: 76953.33333333333
Net tangible assets: 9047032.666666666
Owner earnings: -17633062.666666668
Return on net tangible assets (%): -194.9043771184202
Buffett classification: The Gruesome
Stock price: 0.24666666666666667
Shares outstanding: 267847838
Book value: 9047032.666666666
P/B ratio: 7.302851200787824
Market cap (USD): 66069133.373333335
Debt to equity: 0.01641996945002004
Current ratio: 5.739938499338877
Quick ratio: 5.739938499338877
Interest coverage ratio: -132.36752849759068
Free cash flow (dilution-adjusted): -15542362.666666666
Buyback yield (%): 2.0472192246824976
Retained earnings: -51786780.666666664
Capitalized R&D asset: 2380406.6666666665
ROCI (R&D-adjusted, %): -107.16678645456304
Rule of 40 score: 0
Financial ratios for ICU — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2510
Shares outstanding: 3997002
Market cap (USD): 10032475020
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ICU — annual report dated 2022-12-31
Total revenue: 0
Operating income: -11609000
Net income: -12190000
Capital expenditures: 0
Operating cash flow: -7794000
Net tangible assets: -20762000
Owner earnings: -12190000
Buffett classification: The Gruesome
Stock price: 1025
Shares outstanding: 3997002
Book value: -20762000
Market cap (USD): 4096927050
Debt to equity: -0.4252962142375494
Current ratio: 0.09406737676492445
Quick ratio: 0.09406737676492445
Interest coverage ratio: -18.426984126984127
Free cash flow (dilution-adjusted): -9105000
Buyback yield (%): 0
Retained earnings: -88502000
Receivables turnover: 0
Capitalized R&D asset: 2503000
Rule of 40 score: 0
Financial ratios for ICU — annual report dated 2023-12-31
Total revenue: 0
Gross profit: 0
Operating income: -14210000
Net income: -26232000
Capital expenditures: 0
Operating cash flow: -10285000
Net tangible assets: -13870000
Owner earnings: -26232000
Buffett classification: The Gruesome
Stock price: 110.75
Shares outstanding: 3997002
Book value: -13870000
Market cap (USD): 442667971.5
Debt to equity: -0.6547224224945927
Current ratio: 0.17691246359037252
Quick ratio: 0.17691246359037252
Interest coverage ratio: -13.145235892691952
Free cash flow (dilution-adjusted): -12215000
Buyback yield (%): 0
Retained earnings: -114734000
Capitalized R&D asset: 7650010
Rule of 40 score: 0
Financial ratios for ICU — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 42.6
Shares outstanding: 3997002
Market cap (USD): 170272285.20000002
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ICU — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 19.4
Shares outstanding: 3997002
Market cap (USD): 77541838.8
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ICU — annual report dated 2024-12-31
Total revenue: 135000
Gross profit: 135000
Operating income: -17842000
Net income: -24830000
Capital expenditures: 0
Operating cash flow: -16007000
Net tangible assets: -2183000
Owner earnings: -24830000
Buffett classification: The Gruesome
Stock price: 19.4
Shares outstanding: 3997002
Book value: -2183000
Market cap (USD): 77541838.8
Debt to equity: -0.2629409070087036
Current ratio: 0.5505043122350534
Quick ratio: 0.5505043122350534
Interest coverage ratio: -73.12295081967213
COGS to revenue (%): 0
R&D to revenue (%): 6744.444444444444
SG&A to revenue (%): 6571.851851851852
Free cash flow (dilution-adjusted): -16894000
Buyback yield (%): 0
Retained earnings: -139564000
Receivables turnover: 1.2053571428571428
Capitalized R&D asset: 13932900
ROCI (R&D-adjusted, %): -124.23368142140217
Rosenberg metric: 0.022601707684580613
FCF margin (%): -12514.074074074073
Rule of 40 score: -12514.074074074073
Financial ratios for ICU — quarterly report dated 2025-03-31
Total revenue: 293000
Gross profit: 293000
Operating income: -3822000
Net income: -3772000
Capital expenditures: 0
Operating cash flow: -2654000
Net tangible assets: 565000
Owner earnings: -3772000
Return on net tangible assets (%): -667.6106194690266
Buffett classification: The Gruesome
Stock price: 16.6
Shares outstanding: 3997002
Book value: 565000
P/B ratio: 117.4340410619469
Market cap (USD): 66350233.2
Debt to equity: 0.6424778761061947
Current ratio: 0.9647326507394767
Quick ratio: 0.9584755403868032
Interest coverage ratio: -347.45454545454544
COGS to revenue (%): 0
R&D to revenue (%): 829.6928327645052
SG&A to revenue (%): 574.7440273037543
Free cash flow (dilution-adjusted): -2821000
Buyback yield (%): 0
Retained earnings: -143336000
Inventory turnover: 0
Receivables turnover: 2.6636363636363636
Capitalized R&D asset: 2431000
ROCI (R&D-adjusted, %): -73.47574543836227
FCF margin (%): -962.7986348122868
Rule of 40 score: -962.7986348122868
Financial ratios for ICU — quarterly report dated 2025-06-30
Total revenue: 338000
Gross profit: 311000
Operating income: -1756000
Net income: -2002000
Capital expenditures: 0
Operating cash flow: -3007000
Net tangible assets: 3341000
Owner earnings: -2002000
Return on net tangible assets (%): -59.92217898832685
Buffett classification: The Gruesome
Stock price: 4.26
Shares outstanding: 3997002
Book value: 3341000
P/B ratio: 5.096446728524394
Market cap (USD): 17027228.52
Debt to equity: 0
Current ratio: 1.5166600555335183
Quick ratio: 1.5013883379611266
Interest coverage ratio: -195.11111111111111
COGS to revenue (%): 7.988165680473373
R&D to revenue (%): 306.8047337278106
SG&A to revenue (%): 304.73372781065086
Free cash flow (dilution-adjusted): -3104000
Buyback yield (%): 0
Retained earnings: -145338000
Inventory turnover: 0.35064935064935066
Receivables turnover: 1.5576036866359446
Capitalized R&D asset: 2665770
ROCI (R&D-adjusted, %): -31.21477932399609
Rosenberg metric: 0.007404360345536816
FCF margin (%): -918.3431952662722
Revenue growth (%): 15.358361774744028
Rule of 40 score: -902.9848334915282
Financial ratios for ICU — quarterly report dated 2025-09-30
Total revenue: 183000
Gross profit: 169000
Operating income: -3579000
Net income: -3472000
Capital expenditures: 0
Operating cash flow: -3844000
Net tangible assets: 11464000
Owner earnings: -3472000
Return on net tangible assets (%): -30.286113049546405
Buffett classification: The Gruesome
Stock price: 5.7
Shares outstanding: 3997002
Book value: 11464000
P/B ratio: 1.987343981158409
Market cap (USD): 22782911.400000002
Debt to equity: 0
Current ratio: 3.6581406787998034
Quick ratio: 3.6377274963108706
COGS to revenue (%): 7.650273224043716
R&D to revenue (%): 1010.9289617486338
SG&A to revenue (%): 1037.1584699453551
Free cash flow (dilution-adjusted): -4134000
Buyback yield (%): 0
Retained earnings: -148810000
Inventory turnover: 0.1686746987951807
Receivables turnover: 0.8280542986425339
Capitalized R&D asset: 3347020
ROCI (R&D-adjusted, %): -23.642305976675928
Rosenberg metric: -0.1369334619093539
FCF margin (%): -2259.0163934426228
Revenue growth (%): -45.857988165680474
Rule of 40 score: -2304.8743816083033
Financial ratios for ICU — quarterly report dated 2025-12-31
Total revenue: 420000
Gross profit: 408000
Operating income: -3016000
Net income: -2904000
Capital expenditures: 0
Operating cash flow: -4094000
Net tangible assets: 10416000
Owner earnings: -2904000
Return on net tangible assets (%): -27.880184331797235
Buffett classification: The Gruesome
Stock price: 2.4
Shares outstanding: 3997002
Book value: 10416000
P/B ratio: 0.9209682027649769
Market cap (USD): 9592804.799999999
Debt to equity: 0.05040322580645161
Current ratio: 3.629075360769642
Quick ratio: 3.6114377338321755
Interest coverage ratio: -232
COGS to revenue (%): 2.857142857142857
R&D to revenue (%): 523.8095238095239
SG&A to revenue (%): 291.4285714285714
Free cash flow (dilution-adjusted): -4164000
Buyback yield (%): 0
Retained earnings: -151714000
Inventory turnover: 0.18181818181818182
Receivables turnover: 1.7721518987341771
Capitalized R&D asset: 3781710
ROCI (R&D-adjusted, %): -17.6906463554099
Rosenberg metric: 0.1291891891891892
FCF margin (%): -991.4285714285714
Revenue growth (%): 129.5081967213115
Rule of 40 score: -861.92037470726
Financial ratios for ICU — annual report dated 2025-12-31
Total revenue: 1234000
Gross profit: 1181000
Operating income: -12175000
Net income: -12150000
Capital expenditures: 0
Operating cash flow: -13599000
Net tangible assets: 10416000
Owner earnings: -12150000
Return on net tangible assets (%): -116.64746543778801
Buffett classification: The Gruesome
Stock price: 2.4
Shares outstanding: 3997002
Book value: 10416000
P/B ratio: 0.9209682027649769
Market cap (USD): 9592804.799999999
Debt to equity: 0.05040322580645161
Current ratio: 3.629075360769642
Quick ratio: 3.6114377338321755
Interest coverage ratio: -392.741935483871
COGS to revenue (%): 4.294975688816856
R&D to revenue (%): 609.2382495948136
SG&A to revenue (%): 473.09562398703406
Free cash flow (dilution-adjusted): -14223000
Buyback yield (%): 0
Retained earnings: -151714000
Inventory turnover: 0.803030303030303
Receivables turnover: 5.206751054852321
Capitalized R&D asset: 15589440
ROCI (R&D-adjusted, %): -46.8709623832552
Rosenberg metric: 0.11488193300384404
FCF margin (%): -1152.5931928687196
Revenue growth (%): 814.0740740740741
Rule of 40 score: -338.51911879464546
Financial ratios for KCHV — quarterly report dated 2025-09-30
Total revenue: 0
Operating income: -224660
Net income: 2424046
Capital expenditures: 0
Operating cash flow: -95499
Net tangible assets: 250441720
Owner earnings: 2424046
Return on net tangible assets (%): 0.967908222320147
Buffett classification: The Gruesome
Stock price: 10.03
P/E ratio: 26.713109146856123
Shares outstanding: 25824050
Book value: 250441720
P/B ratio: 1.0342335194791026
Market cap (USD): 259015221.49999997
Debt to equity: 0
Current ratio: 6.025666987910654
Quick ratio: 6.025666987910654
Free cash flow (dilution-adjusted): -95499
Buyback yield (%): 0
Retained earnings: -6118324
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.08728076176765415
Rule of 40 score: 0
Financial ratios for KCHV — annual report dated 2025-12-31
Total revenue: 0
Operating income: -523430
Net income: 5535163
Capital expenditures: 0
Operating cash flow: -490102
Net tangible assets: 252776396
Owner earnings: 5535163
Return on net tangible assets (%): 2.189746783160877
Buffett classification: The Gruesome
Stock price: 10.14
P/E ratio: 47.30770656618424
Shares outstanding: 25824050
Book value: 252776396
P/B ratio: 1.0359189827202062
Market cap (USD): 261855867
Debt to equity: 0
Current ratio: 5.295611494764981
Quick ratio: 5.295611494764981
Free cash flow (dilution-adjusted): -490102
Buyback yield (%): 0
Retained earnings: -6264208
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.20152548745505286
Rule of 40 score: 0
Financial ratios for KCHV — quarterly report dated 2025-12-31
Total revenue: 0
Operating income: -152290
Net income: 2334676
Capital expenditures: 0
Operating cash flow: -121628
Net tangible assets: 252776396
Owner earnings: 2334676
Return on net tangible assets (%): 0.9236131367265794
Buffett classification: The Gruesome
Stock price: 10.14
P/E ratio: 47.30770656618424
Shares outstanding: 25824050
Book value: 252776396
P/B ratio: 1.0359189827202062
Market cap (USD): 261855867
Debt to equity: 0
Current ratio: 5.295611494764981
Quick ratio: 5.295611494764981
Free cash flow (dilution-adjusted): -121628
Buyback yield (%): 0
Retained earnings: -6264208
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.05863308653407332
Rule of 40 score: 0
Financial ratios for KP2.L — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.00013513513513513514
Shares outstanding: 5175938315
Market cap (USD): 699451.1236486486
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for KP2.L — annual report dated 2022-12-31
Total revenue: 0
Operating income: -1527919.277108434
Net income: -1823881.9277108435
Capital expenditures: 5512043.373493976
Operating cash flow: -1489451.8072289156
Net tangible assets: 202666256.62650603
Owner earnings: -7335925.301204819
Return on net tangible assets (%): -3.6197073076275386
Buffett classification: The Gruesome
Stock price: 0.00012048192771084338
Shares outstanding: 5175938315
Book value: 201988287.95180723
P/B ratio: 0.003087342500038428
Market cap (USD): 623607.0259036145
Debt to equity: 0
Current ratio: 7.000553706162149
Quick ratio: 7.000553706162149
Interest coverage ratio: -322.2803049555273
Free cash flow (dilution-adjusted): -7012834.9397590365
Buyback yield (%): 0
Retained earnings: -68426085.54216868
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.7564395404316626
Rule of 40 score: 0
Financial ratios for KP2.L — annual report dated 2023-12-31
Total revenue: 0
Operating income: -1439325.3164556962
Net income: -1379444.3037974683
Capital expenditures: 7317358.2278481005
Operating cash flow: -1590775.9493670885
Net tangible assets: 222345958.22784808
Owner earnings: -8696802.531645568
Return on net tangible assets (%): -3.9113832340201826
Buffett classification: The Gruesome
Stock price: 0.00012658227848101267
Shares outstanding: 5175938315
Book value: 221632024.05063292
P/B ratio: 0.0029561705624282612
Market cap (USD): 655182.0651898735
Debt to equity: 0
Current ratio: 1.4220988543012674
Quick ratio: 1.4220988543012674
Interest coverage ratio: -380.16282179872957
Free cash flow (dilution-adjusted): -8908134.177215189
Buyback yield (%): 0
Retained earnings: -73031356.96202531
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.6413624547074327
Rule of 40 score: 0
Financial ratios for KP2.L — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.00039999999999999996
Shares outstanding: 5175938315
Market cap (USD): 2070375.326
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for KP2.L — annual report dated 2024-12-31
Total revenue: 0
Operating income: -1398233.75
Net income: -1432723.75
Capital expenditures: 3013725
Operating cash flow: -777891.25
Depreciation & amortization: 0
Net tangible assets: 209835507.5
Owner earnings: -4446448.75
Return on net tangible assets (%): -2.1190163680948992
Buffett classification: The Gruesome
Stock price: 0.00025
Shares outstanding: 5175938315
Book value: 209130052.5
P/B ratio: 0.006187463558112959
Market cap (USD): 1293984.57875
Debt to equity: 0
Current ratio: 0.3860488741734695
Quick ratio: 0.3860488741734695
Interest coverage ratio: -332.61581920903956
Free cash flow (dilution-adjusted): -3834816.25
Buyback yield (%): 0
Retained earnings: -72883256.25
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.668595319002542
Rule of 40 score: 0
Financial ratios for KP2.L — quarterly report dated 2024-12-31
Capital expenditures: 691250
Net tangible assets: 209835507.5
Buffett classification: The Gruesome
Stock price: 0.00025
Shares outstanding: 5175938315
Book value: 209130052.5
P/B ratio: 0.006187463558112959
Market cap (USD): 1293984.57875
Debt to equity: 0
Current ratio: 0.3860488741734695
Quick ratio: 0.3860488741734695
Free cash flow (dilution-adjusted): -1006250
Buyback yield (%): 0
Retained earnings: -72883256.25
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for KP2.L — quarterly report dated 2025-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.00025974025974025974
Shares outstanding: 5175938315
Market cap (USD): 1344399.5623376623
Free cash flow (dilution-adjusted): -1233766.2337662338
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for KP2.L — quarterly report dated 2025-06-30
Capital expenditures: 9301058.90410959
Net tangible assets: 271286194.5205479
Buffett classification: The Gruesome
Stock price: 0.000410958904109589
Shares outstanding: 5175938315
Book value: 270512238.3561644
P/B ratio: 0.007863222568402368
Market cap (USD): 2127097.9376712325
Debt to equity: 0
Current ratio: 1.325705337163758
Quick ratio: 1.325705337163758
Free cash flow (dilution-adjusted): -10082097.260273973
Buyback yield (%): 0
Retained earnings: -80467682.19178082
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for KP2.L — annual report dated 2025-12-31
Total revenue: 0
Operating income: -1876981.0810810812
Net income: -1330478.3783783785
Capital expenditures: 15572166.216216216
Operating cash flow: -2483933.7837837837
Depreciation & amortization: 639.1891891891892
Net tangible assets: 283889459.4594595
Owner earnings: -16902005.405405406
Return on net tangible assets (%): -5.95372770711097
Buffett classification: The Gruesome
Stock price: 0.0004054054054054054
Shares outstanding: 5175938315
Book value: 283125829.7297297
P/B ratio: 0.007411380914800398
Market cap (USD): 2098353.370945946
Debt to equity: 0
Current ratio: 23.658830246158388
Quick ratio: 23.658830246158388
Interest coverage ratio: -348.19904738029584
Free cash flow (dilution-adjusted): -18133627.027027026
Buyback yield (%): 0
Retained earnings: -80123187.83783785
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.6629494323682288
Rule of 40 score: 0
Financial ratios for KP2.L — quarterly report dated 2025-12-31
Capital expenditures: 3990540.5405405406
Net tangible assets: 283889459.4594595
Buffett classification: The Gruesome
Stock price: 0.0004054054054054054
Shares outstanding: 5175938315
Book value: 283125829.7297297
P/B ratio: 0.007411380914800398
Market cap (USD): 2098353.370945946
Debt to equity: 0
Current ratio: 23.658830246158388
Quick ratio: 23.658830246158388
Free cash flow (dilution-adjusted): -4706756.756756756
Buyback yield (%): 0
Retained earnings: -80123187.83783785
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for LRE.L — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.04202702702702703
Shares outstanding: 242559721
Market cap (USD): 10194063.950135136
Buyback yield (%): 91.46817569454936
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for LRE.L — annual report dated 2022-12-31
Total revenue: 944457831.3253013
Net income: -18674698.795180723
Capital expenditures: 843373.4939759036
Operating cash flow: 390120481.9277109
Depreciation & amortization: 3734939.7590361447
Net tangible assets: 1390000000
Owner earnings: -15783132.530120483
Return on net tangible assets (%): -1.1354771604403224
Buffett classification: The Gruesome
Stock price: 0.047469879518072286
Shares outstanding: 242559721
Book value: 1597710843.3734941
P/B ratio: 0.007206736299977376
Market cap (USD): 11514280.731807228
Debt to equity: 0.3539702888168313
COGS to revenue (%): 0
Free cash flow (dilution-adjusted): 366506024.09638554
Buyback yield (%): 243.80410561885276
Retained earnings: 19518072.289156627
Receivables turnover: 0.9984715322888804
Capitalized R&D asset: 0
FCF margin (%): 38.805970149253724
Rule of 40 score: 38.805970149253724
Financial ratios for LRE.L — annual report dated 2023-12-31
Total revenue: 1766582278.4810126
Net income: 406962025.31645566
Capital expenditures: 12151898.734177215
Operating cash flow: 559367088.607595
Depreciation & amortization: 5696202.531645569
Net tangible assets: 1679493670.886076
Owner earnings: 400506329.113924
Return on net tangible assets (%): 23.846849562858
Buffett classification: The Gruesome
Stock price: 0.05189873417721518
P/E ratio: 0.03093296597511664
Shares outstanding: 242559721
Book value: 1908734177.2151895
P/B ratio: 0.006595230824988395
Market cap (USD): 12588542.48227848
Debt to equity: 0.31255388288348035
Effective tax rate (%): 3.366396152690111
COGS to revenue (%): 0
Free cash flow (dilution-adjusted): 519113924.0506329
Buyback yield (%): 0
Retained earnings: 230886075.94936708
Capitalized R&D asset: 0
FCF margin (%): 29.385210662080823
Revenue growth (%): 87.04723703779057
Rule of 40 score: 116.43244769987139
Financial ratios for LRE.L — annual report dated 2024-12-31
Total revenue: 2125500000
Net income: 401625000
Capital expenditures: 1875000
Operating cash flow: 717250000
Depreciation & amortization: 9375000
Net tangible assets: 1620375000
Owner earnings: 409125000
Return on net tangible assets (%): 25.24878500347142
Buffett classification: The Gruesome
Stock price: 0.065
P/E ratio: 0.03925647523187053
Shares outstanding: 242559721
Book value: 1866625000
P/B ratio: 0.00844646453626197
Market cap (USD): 15766381.865
Debt to equity: 0.31427040782160315
Effective tax rate (%): 4.5738045738045745
COGS to revenue (%): 0
Free cash flow (dilution-adjusted): 684250000
Buyback yield (%): 0
Retained earnings: 186875000
Capitalized R&D asset: 0
FCF margin (%): 32.192425311691366
Revenue growth (%): 20.317067927773007
Rule of 40 score: 52.509493239464376
Financial ratios for LRE.L — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 1620375000
Buffett classification: The Gruesome
Stock price: 0.065
Shares outstanding: 242559721
Book value: 1866625000
P/B ratio: 0.00844646453626197
Market cap (USD): 15766381.865
Debt to equity: 0.31427040782160315
Buyback yield (%): 0
Retained earnings: 186875000
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for LRE.L — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 1804383561.6438355
Buffett classification: The Gruesome
Stock price: 0.06547945205479452
Shares outstanding: 242559721
Book value: 2073835616.438356
P/B ratio: 0.007658600081775549
Market cap (USD): 15882677.621643836
Debt to equity: 0.3097298368452342
Buyback yield (%): 0
Retained earnings: 222191780.8219178
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MEOH — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 36.65
Shares outstanding: 77364263
Market cap (USD): 2835400238.95
Buyback yield (%): 1.7467017026953795
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MEOH — annual report dated 2022-12-31
Total revenue: 3169991176.470588
Gross profit: 636093382.3529412
Operating income: 362255147.0588235
Net income: 339917647.0588235
Capital expenditures: 424544852.9411764
Operating cash flow: 725991911.7647058
Depreciation & amortization: 273838235.2941176
Net tangible assets: 1552950735.2941175
Owner earnings: 189211029.41176474
Return on net tangible assets (%): 12.183968564587436
Capex to operating income (%): 117.19498160014777
Buffett classification: The Gruesome
Stock price: 35.63
P/E ratio: 8.109283864903265
Shares outstanding: 77364263
Book value: 1786365441.1764703
P/B ratio: 1.5430709904881628
Market cap (USD): 2756488690.69
Debt to equity: 1.2437659938002608
Current ratio: 1.9906006363135824
Quick ratio: 1.524058021444553
Effective tax rate (%): 20.589129549752897
Interest coverage ratio: 3.767950012236907
COGS to revenue (%): 79.93390684887784
Free cash flow (dilution-adjusted): 290124999.99999994
Buyback yield (%): 6.748381844671285
Retained earnings: 1078582352.9411764
Inventory turnover: 7.836126074707063
Receivables turnover: 8.606454059989021
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.660201520057699
FCF margin (%): 9.152233676657104
Rule of 40 score: 9.152233676657104
Financial ratios for MEOH — annual report dated 2023-12-31
Total revenue: 2820814393.939394
Gross profit: 496517424.2424242
Operating income: 199676515.15151516
Net income: 215243939.39393938
Capital expenditures: 339737121.2121212
Operating cash flow: 500203787.8787879
Depreciation & amortization: 296840909.09090906
Net tangible assets: 1462823484.8484848
Owner earnings: 172347727.27272725
Return on net tangible assets (%): 11.781854000695002
Capex to operating income (%): 170.14375524048364
Buffett classification: The Gruesome
Stock price: 45.34
P/E ratio: 16.29637375294557
Shares outstanding: 77364263
Book value: 1646224999.9999995
P/B ratio: 2.130751072556911
Market cap (USD): 3507695684.42
Debt to equity: 1.3869753434970828
Current ratio: 1.1366921445497449
Quick ratio: 0.808985752964357
Effective tax rate (%): 0.5213384638546835
Interest coverage ratio: 2.245735562258235
COGS to revenue (%): 82.3980824364337
Free cash flow (dilution-adjusted): 134328787.87878788
Buyback yield (%): 1.865854131508184
Retained earnings: 1147169696.969697
Inventory turnover: 7.188985270892791
Receivables turnover: 6.977830458289216
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.143641536545161
FCF margin (%): 4.762056949489388
Revenue growth (%): -11.015071118272369
Rule of 40 score: -6.253014168782981
Financial ratios for MEOH — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 40.1
Shares outstanding: 77364263
Market cap (USD): 3102306946.3
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MEOH — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 48.64
Shares outstanding: 77364263
Market cap (USD): 3762997752.32
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MEOH — annual report dated 2024-12-31
Total revenue: 2601279020.979021
Gross profit: 496798601.3986014
Operating income: 227076223.77622378
Net income: 174996503.4965035
Capital expenditures: 121728671.32867134
Operating cash flow: 515509090.90909094
Depreciation & amortization: 269722377.62237763
Net tangible assets: 1464027272.7272727
Owner earnings: 322990209.7902098
Return on net tangible assets (%): 22.06176181325675
Capex to operating income (%): 53.6069647910963
Buffett classification: The Good
Stock price: 48.64
P/E ratio: 21.50327393481428
Shares outstanding: 77364263
Book value: 1665220979.0209794
P/B ratio: 2.2597587946149646
Market cap (USD): 3762997752.32
Debt to equity: 1.3577399584926673
Current ratio: 2.6189379070634415
Quick ratio: 1.997428784456481
Effective tax rate (%): 10.654227630085046
Interest coverage ratio: 2.4482334846268676
COGS to revenue (%): 80.90175650547377
Free cash flow (dilution-adjusted): 377016083.91608393
Buyback yield (%): 0
Retained earnings: 1139430769.2307694
Inventory turnover: 6.636499560052309
Receivables turnover: 7.8587493873273955
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.534187415104533
FCF margin (%): 14.49348881359869
Revenue growth (%): -7.7826947222068705
Rule of 40 score: 6.710794091391819
Financial ratios for MEOH — quarterly report dated 2025-03-31
Total revenue: 626904895.1048951
Gross profit: 220858041.95804197
Operating income: 146660139.86013988
Net income: 92023776.22377622
Capital expenditures: 33081118.881118882
Operating cash flow: 220418181.81818184
Depreciation & amortization: 74197902.0979021
Net tangible assets: 1570226573.4265735
Owner earnings: 133140559.44055946
Return on net tangible assets (%): 8.479066759774547
Capex to operating income (%): 22.556312105433808
Buffett classification: The Great
Stock price: 34.34
P/E ratio: 7.217397775982569
Shares outstanding: 77364263
Book value: 1777452447.5524478
P/B ratio: 1.494660965517396
Market cap (USD): 2656688791.42
Debt to equity: 1.269250758432061
Current ratio: 3.1661102820814815
Quick ratio: 2.5213121765670627
Effective tax rate (%): 21.50717860316968
Interest coverage ratio: 4.136812829161489
COGS to revenue (%): 64.77008814533383
Free cash flow (dilution-adjusted): 204276923.0769231
Buyback yield (%): 0
Retained earnings: 1208016083.916084
Inventory turnover: 1.4160049748817245
Receivables turnover: 2.258792285868344
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.483351088584586
FCF margin (%): 32.584994099103824
Rule of 40 score: 32.584994099103824
Financial ratios for MEOH — quarterly report dated 2025-06-30
Total revenue: 581390510.9489051
Gross profit: 157398540.1459854
Operating income: 82776642.33576642
Net income: 60750364.963503644
Capital expenditures: 22383941.605839413
Operating cash flow: 202086131.3868613
Depreciation & amortization: 74621897.81021897
Net tangible assets: 1915765693.4306567
Owner earnings: 112988321.1678832
Return on net tangible assets (%): 5.897815247205383
Capex to operating income (%): 27.041374201968182
Buffett classification: The Good
Stock price: 32.56
P/E ratio: 16.48826420298498
Shares outstanding: 77364263
Book value: 2130232846.7153282
P/B ratio: 1.1824906404781494
Market cap (USD): 2518980403.28
Debt to equity: 1.2880778942297182
Current ratio: 2.132448228529431
Quick ratio: 1.4334428568340503
Effective tax rate (%): 3.1229993830824925
Interest coverage ratio: 2.214229928147454
COGS to revenue (%): 72.92722581779148
Free cash flow (dilution-adjusted): 179320437.95620438
Buyback yield (%): 0
Retained earnings: 1298837956.2043796
Inventory turnover: 1.1226973232802524
Receivables turnover: 1.6446350956525333
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.6170913972346146
FCF margin (%): 30.84337198134349
Revenue growth (%): -7.260173674090459
Rule of 40 score: 23.58319830725303
Financial ratios for MEOH — quarterly report dated 2025-09-30
Total revenue: 667219424.4604317
Gross profit: 129020863.30935253
Operating income: 49257553.95683453
Net income: 3015107.913669065
Capital expenditures: 4933812.949640288
Operating cash flow: 132512230.21582735
Depreciation & amortization: 79763309.35251799
Net tangible assets: 1849033093.52518
Owner earnings: 77844604.31654677
Return on net tangible assets (%): 4.210016823881507
Capex to operating income (%): 10.016358006660047
Buffett classification: The Great
Stock price: 39.3
P/E ratio: 19.51620893897408
Shares outstanding: 77364263
Book value: 2065457553.9568343
P/B ratio: 1.472030025538613
Market cap (USD): 3040415535.8999996
Debt to equity: 1.2590698805218836
Current ratio: 2.087252585730835
Quick ratio: 1.3266318165650088
Effective tax rate (%): 47.51408891671885
Interest coverage ratio: 1.124657106719887
COGS to revenue (%): 80.66290359971319
Free cash flow (dilution-adjusted): 115633812.94964029
Buyback yield (%): 0
Retained earnings: 1264317985.611511
Inventory turnover: 1.3612486944243274
Receivables turnover: 2.098302461803694
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.0061116418320142
FCF margin (%): 17.330702421193937
Revenue growth (%): 14.762695966854123
Rule of 40 score: 32.09339838804806
Financial ratios for MEOH — quarterly report dated 2025-12-31
Total revenue: 707160583.9416058
Gross profit: 144734306.56934306
Operating income: 52175912.40875912
Net income: -54175912.40875912
Capital expenditures: 10337956.20437956
Operating cash flow: 174680291.9708029
Depreciation & amortization: 92558394.16058393
Net tangible assets: 1783363503.6496348
Owner earnings: 28044525.547445253
Capex to operating income (%): 19.813656775926468
Buffett classification: The Great
Stock price: 39.44
P/E ratio: 30.02801238545022
Shares outstanding: 77364263
Book value: 1990262043.7956204
P/B ratio: 1.5330878374693717
Market cap (USD): 3051246532.72
Debt to equity: 1.2865866248768179
Current ratio: 2.0602130693036385
Quick ratio: 1.3748318293228698
Interest coverage ratio: 1.2562786692209
COGS to revenue (%): 79.533035373293
Free cash flow (dilution-adjusted): 162392700.729927
Buyback yield (%): 0
Retained earnings: 1206770802.919708
Inventory turnover: 1.5576683209849091
Receivables turnover: 2.09241701043174
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.0894967610482615
FCF margin (%): 22.96404867827541
Revenue growth (%): 5.9862105353832895
Rule of 40 score: 28.9502592136587
Financial ratios for MEOH — annual report dated 2025-12-31
Total revenue: 2619871532.846715
Gross profit: 663568613.1386861
Operating income: 338013138.68613136
Net income: 105689051.0948905
Capital expenditures: 72257664.23357664
Operating cash flow: 741284671.5328467
Depreciation & amortization: 325555474.4525547
Net tangible assets: 1783363503.6496348
Owner earnings: 358986861.3138685
Return on net tangible assets (%): 20.129763818717027
Capex to operating income (%): 21.37717619925801
Buffett classification: The Great
Stock price: 39.44
P/E ratio: 28.870034323427767
Shares outstanding: 77364263
Book value: 1990262043.7956204
P/B ratio: 1.5330878374693717
Market cap (USD): 3051246532.72
Debt to equity: 1.2865866248768179
Current ratio: 2.0602130693036385
Quick ratio: 1.3748318293228698
Effective tax rate (%): 28.756783884982706
Interest coverage ratio: 2.1078605860048887
COGS to revenue (%): 74.67171176833767
Free cash flow (dilution-adjusted): 672258394.1605839
Buyback yield (%): 0
Retained earnings: 1206770802.919708
Inventory turnover: 5.418080923453246
Receivables turnover: 7.751936243277682
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.05812707030829
FCF margin (%): 25.659975526743384
Revenue growth (%): 0.7147450049666874
Rule of 40 score: 26.37472053171007
Financial ratios for MSPL.NS — annual report dated 2022-03-31
Total revenue: 305581115.65343535
Gross profit: 35609072.92628247
Operating income: 13063510.483977318
Net income: 3388830.2782539893
Capital expenditures: 3371198.734010286
Operating cash flow: 14519345.90531452
Depreciation & amortization: 7183436.634577344
Net tangible assets: 81509969.66899644
Owner earnings: 7201068.178821046
Return on net tangible assets (%): 8.834585766702943
Capex to operating income (%): 25.806223665110046
Buffett classification: The Good
Stock price: 0.1411051035210339
P/E ratio: 23.600444017900575
Shares outstanding: 566796645
Book value: 81587208.22893313
P/B ratio: 0.9802749843294342
Market cap (USD): 79977899.2680997
Debt to equity: 1.334676901860393
Current ratio: 1.4032901386707604
Quick ratio: 0.6473423502755935
Effective tax rate (%): 14.099952842967081
Interest coverage ratio: 1.502680416124364
COGS to revenue (%): 88.3470963674773
SG&A to revenue (%): 1.150848067357908
Free cash flow (dilution-adjusted): 11141527.100092312
Buyback yield (%): 0
Retained earnings: -31297283.3970724
Inventory turnover: 4.4741961978037255
Receivables turnover: 32.87328751090588
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.64489514877359
FCF margin (%): 3.646012966563059
Rule of 40 score: 3.646012966563059
Financial ratios for MSPL.NS — annual report dated 2023-03-31
Total revenue: 308706577.3447016
Gross profit: 27783045.066991474
Operating income: 2515505.481120585
Net income: -6160791.717417784
Capital expenditures: 6545030.450669915
Operating cash flow: 10450548.112058466
Depreciation & amortization: 6587088.915956152
Net tangible assets: 69404567.60048722
Owner earnings: -6118733.252131548
Return on net tangible assets (%): -8.816038286345574
Capex to operating income (%): 260.1874851711432
Buffett classification: The Gruesome
Stock price: 0.09622411693057248
Shares outstanding: 566796645
Book value: 69457478.68453105
P/B ratio: 0.7852215150516648
Market cap (USD): 54539506.64433618
Debt to equity: 1.4052195728193753
Current ratio: 1.271774338617106
Quick ratio: 0.42915613635821437
Interest coverage ratio: 0.29710965362167263
COGS to revenue (%): 91.00017715658552
SG&A to revenue (%): 1.161511962409661
Free cash flow (dilution-adjusted): 3905517.661388551
Buyback yield (%): 0
Retained earnings: -35069537.149817295
Inventory turnover: 4.76645591097587
Receivables turnover: 33.23539015322882
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.9235171799852062
FCF margin (%): 1.2651229186567192
Revenue growth (%): 1.0227928138108107
Rule of 40 score: 2.28791573246753